The Medicines Control Council (MCC) has granted humanitarian group Doctors Without Borders (MSF) access to a cheaper drug to treat extensively drug-resistant tuberculosis (XDR-TB)... The MCC's decision is the conclusion of a three-year battle for MSF and comes a few weeks after the MSF lodged a high court case against the MCC... This followed the regulatory body's failure to convene a statutory committee to allow MSF to appeal against the MCC's December decision barring it from procuring cheaper XDR-TB treatment. 

Read article below.